4 research outputs found
An alternative approach to determining therapeutic choices in advanced non-small cell lung carcinoma (NSCLC): Maximizing the diagnostic procedure and the use of low-volume lung biopsies
10.1097/01.JTO.0000268671.49378.c2Journal of Thoracic Oncology25387-39
Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
10.1097/JTO.0b013e3181913e28Journal of Thoracic Oncology4112-2
Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis
10.1016/j.cell.2011.11.050Cell1481-2259-272CELL